Product Information
PROPARACAINE 0.5% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $1.4698 per ML under NDC 24208073006. Its NADAC has been published 485 times since Nov 28, 2013.
FDA first approved this application on Sep 29, 1995. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208073006
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PROPARACAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040074FDA Approved
9/29/1995
TE Code
AT
On Market Since
9/29/1995
Pharmacological Classes
Price Statistics
The NADAC for PROPARACAINE 0.5% EYE DROPS has been published 485 times since Nov 28, 2013, and over the history we have for it it has risen 156.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4698 per ML |
|---|---|
| All-time high | $2.2921 (Sep 11, 2019) |
| All-time low | $0.5737 (Nov 28, 2013) |
| 52-week high | $1.7001 |
| 52-week low | $1.4698 |
| Median price | $1.8737 |
| Average price | $1.7499 |
| Largest weekly change | +95.3% (Feb 18, 2015) |
| Weeks tracked | 485 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Proparacaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPARACAINE 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for PROPARACAINE 0.5% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $1.4698 per ML (NDC 24208073006), effective Sep 30, 2026.
How has the price of PROPARACAINE 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for PROPARACAINE 0.5% EYE DROPS has risen 156.2%. It has been tracked across 485 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROPARACAINE 0.5% EYE DROPS?
Since Nov 28, 2013, the NADAC for PROPARACAINE 0.5% EYE DROPS has ranged from a low of $0.5737 (Nov 28, 2013) to a high of $2.2921 (Sep 11, 2019), with a median of $1.8737 per ML.
Are there cheaper alternatives to PROPARACAINE 0.5% EYE DROPS?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROPARACAINE 0.5% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures PROPARACAINE 0.5% EYE DROPS?
PROPARACAINE 0.5% EYE DROPS (NDC 24208073006) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.